Lifera, a subsidiary of the PIF has entered into a joint venture with CENTOGENE, a renowned global omics diagnostics company.
By harnessing this cutting-edge technology, Lifera and CENTOGENE aspire to transform genetic insights into data-driven solutions that will propel the field of precision medicine forward, as highlighted in a press release.